Roles > hydrogen acceptor
Page last updated: 2024-08-05 15:49:04
hydrogen acceptor
A molecular entity that can undergo reduction by the gain of hydrogen atom(s).
ChEBI ID: 13193
Members (1)
| Member | Definition | Class |
|---|
| nad | An anionic form of nicotinamide adenine dinucleotide arising from deprotonation of the two OH groups of the diphosphate moiety. | NAD(1-) |
Research
Studies (28,856)
| Timeframe | Studies, Drugs with This Role(%) | All Drugs % |
|---|
| pre-1990 | 15,311 (53.06) | 18.7374 |
| 1990's | 3,817 (13.23) | 18.2507 |
| 2000's | 3,725 (12.91) | 29.6817 |
| 2010's | 4,026 (13.95) | 24.3611 |
| 2020's | 1,977 (6.85) | 2.80 |
Study Types
| Publication Type | Studies, Drugs with this Role (%) | All Drugs (%) |
|---|
| Trials | 88 (0.29%) | 5.53% |
| Reviews | 1,582 (5.25%) | 6.00% |
| Case Studies | 77 (0.26%) | 4.05% |
| Observational | 8 (0.03%) | 0.25% |
| Other | 28,366 (94.17%) | 84.16% |
Protein Targets (3)
Activation Measurements
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| Chain B, Exotoxin A | Pseudomonas aeruginosa | Kd | 59.5667 | 1 | 9 |